IP Library Granted Patent US 9,273,279
Granted Patent B2
US 9,273,279 · App. 14/217,904 · Granted Mar 1, 2016

Gene inactivated mutants with altered protein production

Inventor: Huaming Wang (Fremont, CA)
Assignee: Danisco US Inc.
C12N1/14C12N9/0061C12N9/48C12N9/62C12N9/88C12N15/52C12P21/00C12P21/02C12Y110/03002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,273,279
App. No.
14/217,904
Granted
Mar 1, 2016
Kind
B2
Abstract

A recombinant filamentous fungal cell (e.g. Aspergillus ) having one or more inactivated chromosomal genes is provided. The chromosomal genes in some embodiments correspond to derA, derB, htmA, mnn9, mnn10, ochA, dpp4, dpp5, pepAa, pepAb, pepAc, pepAd, pepF and combinations thereof. The recombinant fungal cells may include further inactivated chromosomal genes which correspond to pepA, pepB, pepC and pepD. The recombinant filamentous fungal cells may include a heterologous nucleic acid encoding a protein of interest. Also provided are methods of producing a protein of interest in said recombinant filamentous fungal cell.

Claims (20)

1. A method for producing a protein of interest in a filamentous fungal cell comprising

a) obtaining a recombinant filamentous fungal cell comprising one or more inactivated chromosomal genes selected from derB (SEQ ID NO:3), mnn9 (SEQ ID NO:7), mnn10 (SEQ ID NO:9), ochA (SEQ ID NO:11), dpp4 (SEQ ID NO:13), pepAa (SEQ ID NO:17), pepAb (SEQ ID NO:19), pepAc (SEQ ID NO:31), pepAd (SEQ ID NO:21), pepF (SEQ ID NO:23), functionally homologous sequences thereto, wherein the functionally homologous sequences have at least 95% sequence identity thereto, and combinations thereof,

b) introducing a nucleic acid sequence which encodes a protein of interest into said recombinant fungal cell, and

c) growing the recombinant fungal cell under suitable culture conditions for the expression and production of said protein of interest.

2. The method according to claim 1 further comprising recovering the protein of interest.

3. The method according to claim 2 , wherein the expression of the protein of interest is enhanced compared to the expression of said protein of interest in a corresponding parent cell.

4. The method according to claim 3 , wherein the filamentous fungal cell is Aspergillus cell.

5. A method for obtaining a protein of interest from an Aspergillus strain comprising

a) obtaining a recombinant Aspergillus cell comprising one or more inactivated chromosomal genes selected from derB (SEQ ID NO:3), mnn9 (SEQ ID NO:7), mnn10 (SEQ ID NO:9), ochA (SEQ ID NO:11), dpp4 (SEQ ID NO:13), pepAa (SEQ ID NO:17), pepAb (SEQ ID NO:19), pepAc (SEQ ID NO:31), pepAd (SEQ ID NO:21), pepF (SEQ ID NO:23), functionally homologous sequences thereto, wherein the functionally homologous sequences have at least 95% sequence identity thereto, and combinations thereof;

b) transforming the recombinant Aspergillus cell with a nucleic acid sequence encoding a protein of interest;

c) growing the transformed Aspergillus cell under suitable growth conditions to allow expression of the protein of interest, and

d) recovering said protein.

6. The method according to claim 5 , wherein the protein is a protease inhibitor.

7. The method according to claim 5 , wherein the protein is an antibody or fragment thereof.

8. The method according to claim 5 , wherein the protein is an enzyme.

9. The method according to claim 5 , wherein the Aspergillus is A. niger.

10. The method according to claim 1 , wherein the recombinant filamentous fungal cell comprises two inactivated chromosomal genes.

11. The method according to claim 10 , wherein the two inactivated chromosomal genes are mnn9 (SEQ ID NO:7) and ochA (SEQ ID NO:11), or homologous sequences thereto having at least 95% sequence identity thereto.

12. The method according to claim 1 , wherein the inactivated gene has been deleted.

13. The method according to claim 1 , wherein the inactivated gene has been disrupted.

Assignments (2)
CHANGE OF NAME Recorded Apr 11, 2014
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 032670/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: WANG, HUAMING
To: GENENCOR INTERNATIONAL, INC.
Reel/Frame 032645/0599 →
Continuity (4)
Division 12639956 · Dec 16, 2009
Continuation 11401696 · Apr 11, 2006
Provisional Application 60670415 · Apr 12, 2005
Related Publication 20140287462A1 · Sep 25, 2014